Specifically, METTL16-mediated RNA modifications could influence the function and distribution of tumor-associated immune cells, such as tumor-infiltrating lymphocytes and macrophages, thereby contributing to immune evasion and therapy resistance (7). Here, METTL16 is linked to neoplasm.